Skip to main content
  • Edwards Lifesciences treats first patient with Harpoon System in clinical trial

    The HARPOON system was developed at UMB by James. S. Gammie, MD.

    Learn more
  • First Patients Treated with UMB-developed ECMO Technology

    Developed by UMB startup, Breethe, the device was acquired by Abiomed in October 2020.

    Read the story
  • TEDCO Talks: Troy LeMaile-Stovall with special guest Claire Broido Johnson

    Learn how the Momentum Fund is supporting Maryland's entrepreneurial community.

    Watch the Conversation
  • MissionGO sets new record distance for delivering a human organ

    Co-founded by UMSOM's Dr. Joseph Scalea, MissionGO and its sister company, MediGO, are working to make unmanned aircraft a reliable mode of transportation for life-saving cargo.


    Read more
  • GlycoT Therapeutics Grants Sublicense to Daiichi Sankyo

    The agreement provides worldwide, non-exclusive rights to two pieces of University of Maryland, Baltimore technology as well as two pieces of University of Maryland, College Park technology.

    Read more

Spotlight on...

UM Ventures has launched a series of initiatives for the Center for Maryland Advanced Ventures, including:

NEW ACCELERATOR: Trajectory Next
Trajectory Next is a 12-week post-accelerator program for digital health, bio-health, and life sciences startups.

The Baltimore Fund
The Baltimore Fund provides financial incentives to companies affiliated with Maryland Public Higher Education Institutions to locate in a network of innovation centers in Baltimore City.

The UMCP Fischell Institute
The UMCP Fischell Institute for Biomedical Devices is opening a satellite location at UMB to accelerate the development of innovative medical devices.

Maryland Momentum Fund
The University System of Maryland created the Maryland Momentum Fund, a $25 million early-stage investment program investing in USM-affiliated companies. The Maryland Momentum Fund is staffed by UM Ventures.

University of Maryland, Baltimore Institute for Clinical and Translational Research
The University of Maryland, Baltimore Institute for Clinical and Translational Research (ICTR) is pleased to announce the first round of UMB ICTR Accelerated Translational Incubator Pilot (ATIP) Grant funding opportunities for 2018-2019.


University of Maryland, College Park
University of Maryland, Baltimore

UM Ventures is a joint initiative of the University of Maryland, Baltimore and University of Maryland, College Park to commercialize technologies and expand industry collaboration.

Learn More